Silence Therapeutics plc Accounts Payable and Other Accrued Liabilities, Current
Silence Therapeutics plc (SLNCF) had Accounts Payable and Other Accrued Liabilities, Current of $13.36 million as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2026-03-05
- 2025-12-31: Accounts Payable and Other Accrued Liabilities, Current $13.36M.
- 2024-12-31: Accounts Payable and Other Accrued Liabilities, Current $16.40M.
- 2023-12-31: Accounts Payable and Other Accrued Liabilities, Current $15.54M.
| Period end | Accounts Payable and Other Accrued Liabilities, Current |
|---|---|
| 2025-12-31 | $13.36M 10-K · filed 2026-03-05 |
| 2024-12-31 | $16.40M 10-K · filed 2026-03-05 |
| 2023-12-31 | $15.54M 10-K · filed 2025-02-27 |